Experimental drug tested for most dangerous seizures
NCT ID NCT02052739
Summary
This study tested an experimental drug called SAGE-547 in patients with super-refractory status epilepticus, a severe and life-threatening condition where seizures do not stop despite multiple medications. The main goal was to see if the drug was safe and could help control these dangerous seizures. Researchers gave the drug through an IV for four days to 25 patients while they were also receiving standard hospital care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUPER-REFRACTORY STATUS EPILEPTICUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sage Investigational Site
Birmingham, Alabama, 35294, United States
-
Sage Investigational Site
Sarasota, Florida, 34239, United States
-
Sage Investigational Site
Chicago, Illinois, 60611, United States
-
Sage Investigational Site
Wichita, Kansas, 67214, United States
-
Sage Investigational Site
New Orleans, Louisiana, 70121, United States
-
Sage Investigational Site
Boston, Massachusetts, 02114, United States
-
Sage Investigational Site
Boston, Massachusetts, 02115, United States
-
Sage Investigational Site
Ann Arbor, Michigan, 48109, United States
-
Sage Investigational Site
Detroit, Michigan, 48322, United States
-
Sage Investigational Site
New York, New York, 10032, United States
-
Sage Investigational Site
Rochester, New York, 14642, United States
-
Sage Investigational Site
Durham, North Carolina, 27710, United States
-
Sage Investigational Site
Winston-Salem, North Carolina, 27157, United States
-
Sage Investigational Site
Philadelphia, Pennsylvania, 19104, United States
-
Sage Investigational Site
Nashville, Tennessee, 37232, United States
-
Sage Investigational Site
Dallas, Texas, 75251, United States
-
Sage Investigational Site
Temple, Texas, 76504, United States
Conditions
Explore the condition pages connected to this study.